Journal
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
Volume 24, Issue 1, Pages 91-93Publisher
MARY ANN LIEBERT INC
DOI: 10.1089/jop.2007.0058
Keywords
-
Categories
Ask authors/readers for more resources
Erythema multiforme may be a mild condition (erythema multiforme minor), or it may be a severe, possibly life-threatening condition (erythema multiforme major or Stevens-Johnson syndrome). Dorzolamide is a carbonic anhydrase inhibitor, which reduces intraocular pressure by suppressing aqueous production. In this paper we report on a patient who developed erythema multiforme following the use of topical dorzolamide.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available